Although further analyses of more cases are needed to verify and expand upon the present data, our results strongly suggest that the complement of MIC-1 to the current lung cancer biomarkers may greatly improve the detection sensitivity for lung cancer where these markers are currently utilized clinically. The gene discussed is GDF15; the disease is lung cancer.